Study Validates Cervical Sample Test for Endometrial Cancer Detection
The DNA-based test showed 96.8% specificity in cervical samples and could help physicians determine which patients need further testing for endometrial cancer.
Category: Womens Health
Womens Health
Latest
Womens Health
Latest
Study Supports Multi-Omic Blood Test Strategy for Ovarian Cancer Detection
Researchers identified coordinated lipid, metabolite, and protein signatures in symptomatic patients, supporting a multi-omic strategy for earlier ovarian cancer detection.
Womens Health
Latest
Labcorp Launches Companion Diagnostic for Ovarian Cancer Treatment
Labcorp has launched nationwide testing with Agilent’s FDA-approved PD-L1 IHC 22C3 pharmDx, enabling identification of patients with platinum-resistant ovarian cancer eligible for pembrolizumab immunotherapy.
Blood Test for Endometriosis Detection Now Available at IVF Centers
HerAnova Lifesciences has launched HerResolve, the first blood-based test for endometriosis detection, at IVF centers nationwide. Validation studies show diagnostic accuracy comparable to surgical standards, according to the company.
Read More
FDA Approves PD-L1 Test to Guide Immunotherapy in Ovarian and Related Cancers
PD-L1 testing is now cleared to help identify patients with epithelial ovarian, fallopian tube, or primary peritoneal carcinoma who may be eligible for anti–PD-1 therapy.
Read More
Renew Biotechnologies to Provide Clinical Testing for New Male Infertility Diagnostic
The company will process clinical samples for Path Fertility’s NOA Guide, an epigenetic test designed to inform surgical decision-making for men with non-obstructive azoospermia.
Read More
BillionToOne Partners with Epic to Integrate Prenatal, Oncology Tests into EHR
BillionToOne has partnered with Epic to integrate its UNITY Complete prenatal and Northstar oncology tests into Epic’s EHR system, enabling direct ordering and results delivery for healthcare providers.
Read More
ADLM Clinical Chemistry Journal Features Maternal-Fetal Diagnostics
Special issue explores advances in noninvasive prenatal screening, molecular diagnostics, and care disparities affecting perinatal outcomes.
Read More
Noninvasive Prenatal Screening Could Prevent Permanent Hearing Loss in Newborns, Study Finds
Study finds noninvasive prenatal screening using low-cost whole genome sequencing can identify mothers at risk for transmitting virus that causes hearing loss in newborns.
Read More
Roche Receives CE Mark for PCR Test Targeting Bacterial Vaginosis and Candida Vaginitis
The cobas BV/CV assay aims to improve diagnostic accuracy over traditional microscopy and pH testing methods for symptomatic patients.
Read More
Saliva-Based Endometriosis Test Shows 96% Accuracy
The test uses microRNA analysis and AI to diagnose endometriosis in women with chronic pelvic pain when imaging is inconclusive.
Read More
FDA Grants Breakthrough Device Designation to Nanopath’s UTI Diagnostic Platform
The molecular diagnostic system can identify complicated UTI pathogens and antibiotic resistance markers at the point-of-care in approximately 15 minutes.
Read More
Preexisting High Cholesterol in Pregnancy Linked to Elevated CV Risk
Researchers urge clinicians to integrate lipid management into prenatal care to mitigate elevated obstetric complications and cardiovascular risks.
Read More
Fellow Health Joins Progyny Network for Home Male Fertility Testing
Partnership provides mail-in semen analysis as a covered benefit for eligible members.
Read More
New Risk Assessment Tool Could Enhance Ovarian Cancer Detection
The tool uses results from the CA125 blood test along with a woman’s age to generate a personalized risk score for ovarian cancer.
Read More
Natera Launches Fetal Focus Noninvasive Prenatal Test for Inherited Conditions
The new noninvasive prenatal test addresses testing gaps when biological fathers are unavailable for carrier screening by analyzing fetal DNA from maternal blood samples.
Read More
Studies Showcase Less Invasive, More Equitable Testing for Women’s Cancers
At ADLM 2025, researchers spotlight diagnostic innovations that aim to improve gynecologic cancer detection through greater access and less invasive methods.
Read More
Endometriosis Biomarker Detected by Next-Gen Tech
Researchers have developed a highly sensitive, pregnancy-test-like diagnostic device that uses menstrual blood to detect endometriosis early.
Read More